This guideline aims to improve the quality of essential, routine postnatal care for women and
newborns with the ultimate goal of improving maternal and newborn health and well-being …

WHO recommendations uterotonics for the prevention of postpartum haemorrhage: web
annex 7: choice of uterotonic agents WHO recommendations Uterotonics for the prevention of …

Highlights•Preventing deaths from obstetric haemorrhage requires effective health
systems.•The main causes of death associated with antepartum haemorrhage are placental …

Background Postpartum haemorrhage (PPH) is an obstetric emergency. While PPH-related
deaths are relatively rare in high-resource settings, PPH continues to be the leading cause …

Background Several uterotonic options exist for prevention of postpartum hemorrhage
(PPH); hence, cost‐effectiveness is an important decision‐making criterion affecting …

Objective The objective of this study was to estimate the relative cost effectiveness for the full
range of uterotonic drugs available for preventing postpartum haemorrhage (PPH). Methods …

Induction of labor is a common obstetric procedure performed in nearly a quarter of all
deliveries in the United States. Pharmacological (prostaglandins, oxytocin) and/or …

Misoprostol is listed in the WHO essential medicines list and can be used for induction of
labour, for prevention and treatment of post-partum haemorrhage, and for abortions. The …

2. Methods Between June and November 2014, the evaluation team reviewed grantee
reports, proposals, and the literature; interviewed key informants and global, national, and …

En los países en vías de desarrollo, las hemorragias posparto (HPP) son responsables de
100.000 fallecimientos por año. La situación es distinta en los países desarrollados. En …